Teleflex (NYSE:TFX – Get Free Report) and ENDRA Life Sciences (NASDAQ:NDRA – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, earnings, profitability and institutional ownership.
Profitability
This table compares Teleflex and ENDRA Life Sciences’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Teleflex | -35.88% | 13.29% | 6.55% |
| ENDRA Life Sciences | N/A | -433.64% | -204.58% |
Insider and Institutional Ownership
95.6% of Teleflex shares are owned by institutional investors. Comparatively, 1.2% of ENDRA Life Sciences shares are owned by institutional investors. 0.7% of Teleflex shares are owned by company insiders. Comparatively, 10.0% of ENDRA Life Sciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Teleflex | 1 | 5 | 4 | 1 | 2.45 |
| ENDRA Life Sciences | 1 | 0 | 1 | 0 | 2.00 |
Teleflex presently has a consensus target price of $148.00, suggesting a potential upside of 10.08%. ENDRA Life Sciences has a consensus target price of $25.00, suggesting a potential upside of 363.82%. Given ENDRA Life Sciences’ higher probable upside, analysts clearly believe ENDRA Life Sciences is more favorable than Teleflex.
Valuation & Earnings
This table compares Teleflex and ENDRA Life Sciences”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Teleflex | $1.99 billion | 2.99 | -$905.64 million | ($22.80) | -5.90 |
| ENDRA Life Sciences | N/A | N/A | -$7.03 million | ($8.15) | -0.66 |
ENDRA Life Sciences has lower revenue, but higher earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than ENDRA Life Sciences, indicating that it is currently the more affordable of the two stocks.
Volatility & Risk
Teleflex has a beta of 0.82, suggesting that its stock price is 18% less volatile than the S&P 500. Comparatively, ENDRA Life Sciences has a beta of -0.06, suggesting that its stock price is 106% less volatile than the S&P 500.
Summary
Teleflex beats ENDRA Life Sciences on 8 of the 14 factors compared between the two stocks.
About Teleflex
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
About ENDRA Life Sciences
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.
